Capital Advisors Inc. OK Buys 1,858 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Advisors Inc. OK raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 129,751 shares of the medical equipment provider's stock after buying an additional 1,858 shares during the period. Intuitive Surgical accounts for about 1.3% of Capital Advisors Inc. OK's portfolio, making the stock its 16th largest holding. Capital Advisors Inc. OK's holdings in Intuitive Surgical were worth $67,725,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $82,517,000. Sycomore Asset Management increased its stake in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC increased its stake in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its stake in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

ISRG has been the topic of several recent analyst reports. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $613.10.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $4.16 on Friday, reaching $595.55. 1,188,781 shares of the stock were exchanged, compared to its average volume of 1,979,754. The firm's 50 day moving average is $559.48 and its 200-day moving average is $519.06. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market cap of $212.12 billion, a PE ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company's stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.90% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.